Ireland NCR. Data & statistics 2024[Available from: https://www.ncri.ie/data].
UK CR. Breast cancer statistics [Available from: https://www.cancerresearchuk.org/healthprofessional/cancer-statistics/statistics-by-cancer-type/breast-cancer].
Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nat Rev Clin Oncol. 2020;17:329–31.
Article CAS PubMed PubMed Central Google Scholar
Figueroa JD, Gray E, Pashayan N, Deandrea S, Karch A, Vale DB, et al. The impact of the Covid-19 pandemic on breast cancer early detection and screening. Prev Med. 2021;151:106585.
Article PubMed PubMed Central Google Scholar
Mays N, Pope C, Popay J. Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field. J Health Serv Res Policy. 2005;10:6–20.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73.
Covidence systematic review software. Veritas Health Innovation, Melbourne, Australia.
Armitage RC, Morling JR. The impact of COVID-19 on national screening programmes in England. Public Health. 2021;198:174–6.
Article CAS PubMed Google Scholar
Borsky K, Shah K, Cunnick G, Tsang-Wright F. Pattern of breast cancer presentation during the COVID-19 pandemic: results from a cohort study in the UK. Future Oncol. 2022;18:437–43.
Article CAS PubMed Google Scholar
Cathcart P, Smith S, Clayton G. Strengths and limitations of video-conference multidisciplinary management of breast disease during the COVID-19 pandemic. Br J Surg. 2021;108:e20–e1.
Article CAS PubMed Google Scholar
Clark JJ, Dwyer D, Pinwill N, Clark P, Johnson P, Hackshaw A. The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis. Lancet Oncol. 2021;22:66–73.
Article CAS PubMed Google Scholar
Duffy SW, Seedat F, Kearins O, Press M, Walton J, Myles J, et al. The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation. Br J Cancer. 2022;126:1355–61.
Article CAS PubMed PubMed Central Google Scholar
Gathani T, Clayton G, MacInnes E, Horgan K. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. Br J Cancer. 2021;124:710–2.
Article CAS PubMed Google Scholar
Gathani T, Reeves G, Dodwell D, Horgan K, Kearins O, Kan SW, et al. Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in England. Br J Surg. 2022;109:29–30.
Gathani T, Dodwell D, Horgan K. The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England. Br J Cancer. 2023;128:481–3.
Ho W, Köhler G, Haywood RM, Rosich-Medina A, Masud D. Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience. J Plast Reconstr Aesthet Surg. 2022;75:112–7.
Hudson SM, Binysh K, Duffy SW. Did the use of open invitations in place of timed appointment invitations reduce the uptake of breast screening in the London region during the COVID-19 recovery? J Med Screen. 2023;30:87–91.
Joseph AO, Joseph JP, Pereira B, Gahir J. Coronavirus outbreak: reorganising the breast unit during a pandemic. Eur J Surg Oncol. 2020;46:1176–7.
Article PubMed PubMed Central Google Scholar
MacInnes EG, Piper J, Tait C, Waterworth A, Achuthan R, Hogan B, et al. Breast cancer surgery during the COVID-19 pandemic peak in the UK: operative outcomes. Cureus 2020;12:e9280.
PubMed PubMed Central Google Scholar
Markeson D, Freeman Romilly N, Potter M, Tucker S, Kalu P. Restarting plastic surgery: drawing on the experience of the initial COVID-19 pandemic to inform the safe resumption of services. J Plast Reconstr Aesthet Surg. 2020;73:2121–6.
Article CAS PubMed PubMed Central Google Scholar
Purushotham A, Roberts G, Haire K, Dodkins J, Harvey-Jones E, Han L, et al. The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients. Ecancermedicalscience 2021;15:1180.
Article PubMed PubMed Central Google Scholar
Shetty G, Datta U, Rea I, Rai S, Hwang MJ, Hoar F, et al. Rapid implementation of triaging system for assessment of breast referrals from primary care centres during the COVID-19 pandemic. Ann R Coll Surg Engl. 2021;103:576–82.
Article CAS PubMed PubMed Central Google Scholar
Spencer K, Jones CM, Girdler R, Roe C, Sharpe M, Lawton S, et al. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study. Lancet Oncol. 2021;22:309–20.
Article CAS PubMed PubMed Central Google Scholar
Baxter MA, Murphy J, Cameron D, Jordan J, Crearie C, Lilley C, et al. The impact of COVID-19 on systemic anticancer treatment delivery in Scotland. Br J Cancer. 2021;124:1353–6.
Article CAS PubMed PubMed Central Google Scholar
Campbell C, Sommerfield T, Clark GRC, Porteous L, Milne AM, Millar R, et al. COVID-19 and cancer screening in Scotland: a national and coordinated approach to minimising harm. Prev Med. 2021;151:106606.
Article PubMed PubMed Central Google Scholar
Grocutt L, Rutherford A, Caldwell D, Wilkinson C, Chalmers AJ, Dempsey L, et al. The impact of COVID-19 on radiotherapy services in Scotland, UK: a population-based study. Clin Oncol. 2023;35:e227–e34.
Romics L, Doughty J, Stallard S, Mansell J, Blackhall V, Lannigan A, et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast 2021;55:1–6.
Bansal GJ, Saleem Z. The symptomatic breast services in a university hospital: pandemic peak compared to the pre-pandemic year and future implications. Ir J Med Sci. 2022;191:2475–9.
Article CAS PubMed PubMed Central Google Scholar
Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, et al. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer. 2022;127:558–68.
Article CAS PubMed PubMed Central Google Scholar
Higgins E, Walters S, Powell E, Staffurth J. The impact of the acute phase of COVID-19 on radiotherapy demand in South East Wales. Clin Oncol (R Coll Radio). 2020;32:e217.
Mitchell H, McLean J, Gavin AT, Visser O, Millar E, Luff T, et al. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland. BMC Cancer. 2023;23:700.
Article PubMed PubMed Central Google Scholar
Bansal GJ, Chopra S. Symptomatic breast services in the post-COVID-19 era. Br J Hosp Med. 2021;82:1–3.
Dave RV, Kim B, Courtney A, O’Connell R, Rattay T, Taxiarchi VP, et al. Publisher Correction: breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ’Alert Level 4’ phase of the B-MaP-C study. Br J Cancer. 2021;125:905.
Article CAS PubMed PubMed Central Google Scholar
Gatfield ER, Mukesh MB, Loo SW. Adjuvant systemic anti-cancer therapy in early breast cancer during the COVID-19 pandemic: differences between clinicians and patients in perception of treatment risks and benefits. Clin Oncol. 2020;32:e218.
O’Connor E, O’Dowd G, Phelan S. Impact of COVID-19 on small biopsy diagnostic procedures and cancer resection surgeries in the North-West of Ireland. J Clin Pathol. 2022;75:270–3.
Elghobashy M, Wahab L, Gunavardhan A, O’Sullivan E, Provenzano E, Deb R, et al. Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland. J Clin Pathol. 2023;76:234–8.
Gannon MR, Dodwell D, Miller K, Horgan K, Clements K, Medina J, et al. Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: a population-based cohort study of older women in England and Wales. Clin Oncol. 2022;34:e400–e9.
Greene GJ, Thomson CS, Donnelly D, Chung D, Bhatti L, Gavin AT, et al. Whole-population trends in pathology-confirmed cancer incidence in Northern Ireland, Scotland and Wales during the SARS-CoV-2 pandemic: a retrospective observational study. Cancer Epidemiol. 2023;84:102367.
留言 (0)